Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sandip Basu

Showing results (21-30 of 519) with videos related to

Pageof 52
Sort By:
Journal of Nuclear Medicine Technology|December 8, 2021
Discordance Between Histopathologic Grading and Dual-Tracer PET/CT Findings in Metastatic NETs and Outcome of <sup>177</sup>Lu-DOTATATE PRRT: Does In Vivo Molecular PET Perform Better from the Viewpoint of Prediction of Tumor Biology?Aadil Adnan, Sandip Basu
Journal of Cancer Research and Therapeutics|November 3, 2011
Primary paraganglioma of thyroid presenting as solitary thyroid massSandip Basu, Seethalakshmi Viswanathan
Hellenic Journal of Nuclear Medicine|November 17, 2011
A pregnant woman with metastatic papillary thyroid carcinoma and paraplegia: Multiple considerations involved in the managementSandip Basu, Purushottam Kand
European Journal of Nuclear Medicine and Molecular Imaging|July 3, 2008
Planar and SPECT imaging in the era of PET and PET-CT: can it survive the test of time?Abass Alavi, Sandip Basu
Journal of Nuclear Medicine Technology|May 3, 2020
Combined <sup>177</sup>Lu-DOTATATE Peptide Receptor Radionuclide Therapy and Platinum-Based Chemotherapy in Recurrent, Metastatic Sinonasal Neuroendocrine Carcinoma: A Promising Therapeutic OptionAadil Adnan, Sandip Basu
Japanese Journal of Radiology|June 6, 2009
Fluorodeoxyglucose-positron emission tomography imaging characteristics of unusual cystic metastasis on the liver surface arising from gallbladder carcinomaSandip Basu, Ramesh Rao
European Journal of Nuclear Medicine and Molecular Imaging|April 2, 2017
Envisaging an alpha therapy programme in the atomic energy establishments: the priorities and the nuancesSandip Basu, Sharmila Banerjee
European Journal of Nuclear Medicine and Molecular Imaging|February 26, 2017
Monitoring metastatic lesions in TENIS, initiating multi-targeted tyrosine kinase inhibitors and follow-up: should the newer FDG PET-CT quantitative indices be the defining objective parameter in clinical trials?Sandip Basu, Ashwini Kalshetty
World Journal of Nuclear Medicine|February 21, 2017
Metabolic Bone Disease in the Context of Metastatic Neuroendocrine Tumor: Differentiation from Skeletal Metastasis, the Molecular PET-CT Imaging Features, and Exploring the Possible Etiopathologies Including Parathyroid Adenoma (MEN1) and Paraneoplastic Humoral Hypercalcemia of Malignancy Due to PTHrP HypersecretionRohit Ranade, Sandip Basu
Nuclear Medicine Communications|December 2, 2016
Developing a dedicated comprehensive α-radionuclide therapy program: should this be the vision of the atomic energy programs in the next decade?Sandip Basu, Sharmila Banerjee
Pageof 52

Showing results (21-30 of 519) with videos related to

Sort By:
Pageof 52
Journal of Nuclear Medicine Technology|December 8, 2021
Discordance Between Histopathologic Grading and Dual-Tracer PET/CT Findings in Metastatic NETs and Outcome of <sup>177</sup>Lu-DOTATATE PRRT: Does In Vivo Molecular PET Perform Better from the Viewpoint of Prediction of Tumor Biology?Aadil Adnan, Sandip Basu
Journal of Cancer Research and Therapeutics|November 3, 2011
Primary paraganglioma of thyroid presenting as solitary thyroid massSandip Basu, Seethalakshmi Viswanathan
Hellenic Journal of Nuclear Medicine|November 17, 2011
A pregnant woman with metastatic papillary thyroid carcinoma and paraplegia: Multiple considerations involved in the managementSandip Basu, Purushottam Kand
European Journal of Nuclear Medicine and Molecular Imaging|July 3, 2008
Planar and SPECT imaging in the era of PET and PET-CT: can it survive the test of time?Abass Alavi, Sandip Basu
Journal of Nuclear Medicine Technology|May 3, 2020
Combined <sup>177</sup>Lu-DOTATATE Peptide Receptor Radionuclide Therapy and Platinum-Based Chemotherapy in Recurrent, Metastatic Sinonasal Neuroendocrine Carcinoma: A Promising Therapeutic OptionAadil Adnan, Sandip Basu
Japanese Journal of Radiology|June 6, 2009
Fluorodeoxyglucose-positron emission tomography imaging characteristics of unusual cystic metastasis on the liver surface arising from gallbladder carcinomaSandip Basu, Ramesh Rao
European Journal of Nuclear Medicine and Molecular Imaging|April 2, 2017
Envisaging an alpha therapy programme in the atomic energy establishments: the priorities and the nuancesSandip Basu, Sharmila Banerjee
European Journal of Nuclear Medicine and Molecular Imaging|February 26, 2017
Monitoring metastatic lesions in TENIS, initiating multi-targeted tyrosine kinase inhibitors and follow-up: should the newer FDG PET-CT quantitative indices be the defining objective parameter in clinical trials?Sandip Basu, Ashwini Kalshetty
World Journal of Nuclear Medicine|February 21, 2017
Metabolic Bone Disease in the Context of Metastatic Neuroendocrine Tumor: Differentiation from Skeletal Metastasis, the Molecular PET-CT Imaging Features, and Exploring the Possible Etiopathologies Including Parathyroid Adenoma (MEN1) and Paraneoplastic Humoral Hypercalcemia of Malignancy Due to PTHrP HypersecretionRohit Ranade, Sandip Basu
Nuclear Medicine Communications|December 2, 2016
Developing a dedicated comprehensive α-radionuclide therapy program: should this be the vision of the atomic energy programs in the next decade?Sandip Basu, Sharmila Banerjee
Pageof 52